Soleus Capital Management, L.P. - MEDICENNA THERAPEUTICS CORP ownership

MEDICENNA THERAPEUTICS CORP's ticker is MDNA and the CUSIP is 58490H107. A total of 26 filers reported holding MEDICENNA THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of MEDICENNA THERAPEUTICS CORP
ValueSharesWeighting
Q4 2020$874,000
-15.1%
186,799
-24.9%
0.12%
-78.9%
Q3 2020$1,030,000248,8600.55%
Other shareholders
MEDICENNA THERAPEUTICS CORP shareholders Q3 2023
NameSharesValueWeighting ↓
AIGH Capital Management LLC 2,272,700$2,647,0000.70%
Worth Venture Partners, LLC 571,489$846,0000.50%
ACT CAPITAL MANAGEMENT, LLC 149,070$173,0000.24%
Verition Fund Management LLC 539,051$631,0000.01%
Sigma Planning Corp 252,050$292,0000.01%
McKinley Carter Wealth Services, Inc. 79,259$92,0000.01%
Patriot Financial Group Insurance Agency, LLC 17,900$21,0000.00%
LETKO, BROSSEAU & ASSOCIATES INC 100,000$116,0000.00%
TOCQUEVILLE ASSET MANAGEMENT L.P. 113,000$132,0000.00%
Rathbones Group PLC 40,000$46,0000.00%
View complete list of MEDICENNA THERAPEUTICS CORP shareholders